|
|
||||||||
1 From the Department of Ophthalmology, University of Rochester School of Medicine, New York; and the 2 Wilmer Ophthalmological Institute and the 3 Department of Pathology, the Johns Hopkins Medical Institutions, Baltimore, Maryland.
| Abstract |
|---|
|
|
|---|
METHODS. Serial sections of the posterior segment of the eye and the transplanted areas were processed and studied by routine histologic techniques, including both light and transmission electron microscopy (TEM). Transplanted areas were also examined for the presence of glial, neuronal, and photoreceptor cell markers by standard immunohistochemical methods.
RESULTS. After transplantation in this patient, there was no visual improvement. Light microscopic examination disclosed survival of the transplanted cells in the subretinal space with no evidence of inflammation or rejection. The neural retinal sheet transplant developed a layered configuration. The retinal pigment epithelium (RPE) was absent over much of the posterior pole, including the area of transplantation. TEM examination and immunohistochemical analysis disclosed the presence of neuronal and glial cells within the transplant. A few transplant neuronal cell processes overlying a focus of residual RPE cells were positive for S-antigen, but well-developed photoreceptor outer segments were not present.
CONCLUSIONS. Long-term survival of transplanted neural retinal tissue can be achieved in human patients without immunosuppression. The lack of photoreceptor development in this patient may be the result of absent or dysfunctional RPE. Nonetheless, the long-term survival of grafted tissue in the human subretinal space in the absence of immunosuppressive treatment is promising for future efforts in the field of neural retinal transplantation.
| Introduction |
|---|
|
|
|---|
A number of rodent (rat and mouse) models of retinal transplantation have been developed.4 5 6 7 8 9 10 11 12 13 14 These models have shown that retinal tissue transplanted into subretinal space can survive and differentiate normally.
The encouraging results from animal studies have prompted initial investigations of the feasibility of human transplantation. Kaplan and coworkers15 transplanted a sheet of photoreceptor cells from cadaveric human eyes into two patients with RP (no light perception visual acuity), without immunosuppression. Although there was no improvement in visual function during the 12-month follow-up period, there was no clinical evidence of inflammation within the eyes, including at the graft sites. Humayun and coworkers16 transplanted microaggregate suspensions of fetal tissue into the subretinal space of eight patients with RP and one patient with AMD. The patient with AMD also received a fetal retinal sheet transplant. This patient died from a cerebrovascular accident 3 years after the transplantation procedure. The transplanted eye was obtained postmortem for microscopic study, and the histologic features are described in this report.
| Methods |
|---|
|
|
|---|
|
|
Transmission Electron Microscopy
Two unstained 8-µm-thick paraffin-embedded sections from the
area of fetal sheet transplantation were retrieved from the slide and
reprocessed for transmission electron microscopy according to a
previously reported technique.18
Immunohistochemistry
Immunohistochemical staining was performed according to the
streptavidin peroxidase method previously described by Lutty and
coworkers,19
using the Vectastain
avidin-biotin-complexhorseradish peroxidase (ABCHRP) kit (Vector
Laboratories, Burlingame, CA). Briefly, 8-µm-thick unstained sections
were deparaffinized with Xylene for 10 minutes (two times), rehydrated
with serial ethanol washes, treated with hydrogen peroxide for 30
minutes, and blocked with 10% goat serum and the ABCHRP blocking
kit.
Primary antibodies were obtained from a variety of sources. Sheep
anti-serum against bovine opsin was provided courtesy of David
Papermaster (University of Texas Health Science Center, San Antonio,
TX) and was used at a dilution of 1:2000. Rabbit anti-
-aminoGABA
antibody was generously provided by Ruben Adler (Wilmer Eye Institute,
Johns Hopkins University, Baltimore, MD) and was used at a titer of
1:10,000. Rabbit anti-human synaptophysin (DAKO, Carpinteria, CA) was
used at a 1:1000 dilution. Rabbit anti-S-antigen was a gift from
Igal Gery (National Eye Institute, Bethesda, MD) and used at a
titer of 1:1000. Rabbit antiserum against S-100 protein (ICN
Biochemicals, Aurora, IL) was used at 1:1000. Rabbit antiglial
fibrillary acidic protein (GFAP; DAKO) and rabbit antineuron-specific
enolase (NSE; DAKO) were both used at dilutions of 1:50. All dilutions
were performed with phosphate-buffered saline (PBS).
Histologic sections were incubated with the various primary antibodies (at the concentrations described above) for 20 hours at 4°C. Secondary antibodies (biotinylated rabbit anti-sheep IgG, goat anti-rabbit IgG, or goat anti-mouse IgG; Kirkegaard and Perry Labs, Gaithersburg, MD) were prepared by preadsorption with human serum for 30 minutes at 37°C (1 part antibody, 9 parts serum), followed by a further 1:50 dilution. After washing, sections were incubated for 30 minutes at room temperature with secondary antibodies diluted 1:500. Sections were then incubated with streptavidin labeled with peroxide in PBS (1:500 dilution; Kierkegaard and Perry Labs). Finally, the ABC-peroxidase complex was detected using 3-amino-9-ethylcarbazol as the substrate. Some sections were counterstained with Harris hematoxylin.
For each immunohistochemical marker, positive and negative controls were also performed. Positive controls included paraffin sections through the posterior poles of the globes of an 81-year-old man with neovascular AMD (but with preservation of most photoreceptor outer segments) and a 73-year-old man with a normal retina by microscopic examination. Negative controls were performed (on the same patients as the positive controls) for each immunohistochemical marker by substituting PBS for the primary antibody or by substituting nonimmune rabbit IgG (0.4 µg/ml). The transplant sections were not used as negative controls because of the limited supply of available sections.
TdT-dUTP Terminal Nick-End Labeling
In situ detection of apoptotic cells was performed using the TACS
Blue Label Detection kit (Trevigen, Gaithersburg, MD) according
to the manufacturers protocol. Briefly, sections were deparaffinized,
dehydrated, and rehydrated. The sections were then treated with
proteinase K to increase tissue permeability, followed by 2%
H2O2 to quench the
endogenous peroxides. Sections were then in situ-labeled with a dNTP
mix and terminal deoxynucleotidyl transferase in the presence of
MnCl2 at 37°C.
The reaction was stopped with stop buffer. StreptavidinHRP conjugate was then added to the tissue. The positive signal was visualized by blue label and counterstained with red Counterstain C.
| Results |
|---|
|
|
|---|
Fetal Sheet Transplant.
A 2.0-mm segment of donor retina was present external to the host
retina with a thin membrane located at the graft-host interface (Fig. 1B)
. This membrane was not continuous, and there was apparent contact
between donor and recipient cells at these discontinuities (Fig. 1C)
.
No donor ganglion cells were present, but the transplanted cells were
organized in a layered configuration in some areas. In other areas,
however, the cells were scattered and more loosely arranged. Also, in
some locations the transplanted tissue adopted a "rolled-up"
configuration. The inner nuclear layer was relatively intact and was
apparently continuous with the recipients inner nuclear layer at the
nasal and temporal margins of the transplant (Fig. 3)
. In one area there was a focus of neurons with cytoplasmic extensions
(possible photoreceptors) overlying a small patch of residual RPE
cells; this area was studied by immunohistochemical techniques
(S-antigen stain, Fig. 4
). However, the RPE was largely absent over much of the macular and
perimacular regions, including the areas of transplantation (Fig. 1B)
.
There was no inflammation in the recipient or fetal retina or in the
subjacent choroid.
|
|
Transmission Electron Microscopy
Examination of two sections through the fetal sheet transplant
disclosed a zone of transplanted cells between the recipient retina and
choroid. In some areas the transplant and the recipient retinas were
separated by a fibrocellular membrane composed of Müller cell
processes, cellular debris, and collagen (10-nm fiber diameter).
Preservation of ultrastructural detail was generally poor, thus
impairing the characterization of constituent cells. Several round
cells (possible donor neural cells) and a few larger oval-to-round
cells (possible Müller cells) were present within the donor
retina. Other cell types could not be clearly identified. No definite
photoreceptor inner and outer segments were identified (illustrations
not shown).
Immunohistochemical Analysis
Unstained sections through both areas of transplantation (fetal
sheet and microaggregate) were studied by a variety of immunostaining
techniques (Table 1)
. Some transplanted cells did stain positively for GFAP, S-100, GABA,
NSE, and synaptophysin, indicating the presence of both glial and
neuronal cells within the transplant (Fig. 4A 4B
4C
4D)
. The
donor tissue stained weaker than the host cells with S-100 but clearly
stronger than the negative control (not shown). A few possible GABA+
and synaptophysin+ cell processes were noted to extend between the
transplant and the host retina (Figs. 4A
4B)
. The cells identified as
possible primitive photoreceptors by light microscopy were weakly
positive for S-antigen (Fig. 4C)
. The opsin stain was negative in the
transplant, but this stain was performed on a different transplant area
that did not contain intact RPE. TdT-dUTP terminal nick-end labeling
(TUNEL labeling) was negative in sections through both transplanted
areas (illustration not shown).
|
| Discussion |
|---|
|
|
|---|
In this report, we describe a patient with AMD who underwent transplantation of both a microaggregate suspension and an intact sheet of fetal neural retina into the subretinal space. The patient died 3 years after the procedure. Clinically, the patients eye showed no evidence of rejection. Fluorescein angiography did not show evidence of diffuse leakage (only staining), suggesting that the transplant was not causing a significant local breakdown of the bloodretina barrier (a finding that would be expected if there was an inflammatory reaction by the host). The transplanted tissue was still present in the subretinal space after 3 years, with no evidence of inflammatory cells in the vicinity of the graft to suggest active cell-mediated rejection. Furthermore, no apoptosis was evident by TUNEL labeling. However, the percentage of cells that survived cannot be determined. Certainly, it is possible that some cells were lost over the course of 3 years as a result of inflammation (including rejection), apoptosis, or other cell-death mechanisms, which were not active at the time of the patients death. Nonetheless, the survival of a significant amount of transplanted tissue without the use of systemic immunosuppression is a promising finding. The lack of inflammation and rejection of the transplanted tissue may be a reflection of the relatively low immunogenicity of fetal tissue. In addition, neuronal cells, particularly photoreceptors, do not express detectable levels of major histocompatibility complex (MHC) class I molecules.23 24 25 This feature further reduces the likelihood of inciting an immune reaction. Of note, however, Larsson and coworkers23 found an upregulation of MHC class I antigen expression in allogeneic retinal transplants in rats but no change in expression in syngeneic transplants. However, this difference in expression did not correlate with rejection or decreased survival of the transplant. Thus, these investigators concluded that allogeneic transplants into the subretinal space are recognized as "non-self" but some modification of the immune response occurs that prevents rejection.
The transplanted tissue in this patient demonstrated some features suggestive of primitive retinal development. In some areas of the fetal sheet transplant, the cells were organized in a layered configuration. The component cell types of the transplanted tissue were characterized by a variety of immunohistochemical stains. Antibody stains for GABA,26 27 an important inhibitory neurotransmitter in retinal neuronal cells, and synaptophysin,28 an N-glycosylated integral membrane protein of synaptic vesicles, were positive, thus confirming the presence of neuronal cells within the transplant. In addition, the presence of synaptophsyin suggests that the transplanted cells have the potential to form synaptic connections. Moreover GABA-positive and synaptophysin-positive neuronal cell processes were present between the host and the transplant tissues. This suggests that there was some degree of attempted integration (at least structural) of the transplant into the recipient retina. However, it was not possible to determine whether synapses formed between host and transplant neurons.
Glial cells were also present within the transplant. S-10029 is a calcium-binding protein, which is present in the cell bodies and processes of retinal astrocytes and Müller cells. GFAP29 is a structural protein expressed in the processes of retinal astrocytes and also in Müller cell processes after retinal injury or damage. Retinal astrocytes are believed to migrate to the retina from the optic nerve head, whereas Müller cells arise from intrinsic retinal cells.29 Transplanted tissue from both the microaggregate and intact sheet regions stained positively for both S-100 and GFAP. Although within the transplant retinal astrocytes and Müller cells could not be distinguished with certainty by light microscopy or immunohistochemical stains, possible Müller cells were identified by electron microscopy. These Müller cells could have differentiated from the transplanted fetal cells or migrated from the host retina.
Definite photoreceptor outer segments could not be identified by light or electron microscopy. There was, however, a single small focus of cells that stained positively for S-antigen. S-antigen30 31 32 33 is a photoreceptor cellspecific protein that is present predominantly in rod outer segments. Unfortunately, additional sections were not available through this small area to look for ultrastructural features of photoreceptor differentiation. Nonetheless, the S-antigen staining suggests that some transplanted cells with possible primitive photoreceptor differentiation remained. Of note, these remaining possible photoreceptors were located internal to a small focus of residual RPE cells. It has been well established that functional RPE cells are crucial for the maintenance and survival of photoreceptors. The RPE was absent over much of the posterior poles in both eyes of this patient (fellow eye examined microscopically but not described in this report), including the areas of transplantation in the left eye. Residual hypertrophic RPE cells were present in some areas of the posterior pole, but they were often arranged in tubuloacinar configurations and other structures incompatible with normal function. The lack of functional RPE is a potential cause for the paucity of photoreceptor cells within the transplant.
The RPE may have been lost for a variety of reasons. Some RPE loss may be a reflection of the patients advanced AMD. Certainly, RPE atrophy is an important feature of AMD. This hypothesis is supported by the observation that the RPE loss was present in both eyes. In addition, RPE cells may been lost during the evacuation of submacular hemorrhage in the left eye 9 months before the transplantation procedure. Finally, some RPE loss may have occurred as a direct result of transplantation procedure. Although a very slow infusion of fluid accompanied the insertion of fetal tissue, direct trauma from the fluid wave or the insertion forceps (in the case of the sheet transplant) may have disrupted the RPE. All three mechanisms likely contributed to RPE loss, but the relative contributions of each mechanism cannot be precisely determined.
In some areas, in both the microaggregate and the sheet transplants, a membrane was evident between the internal surface of the transplanted tissue and the recipient retina. The membrane was of variable thickness and composed of Müller cell processes, cellular debris, and collagen. The relative contributions of the recipient and the donor to the formation of this membrane are unclear. This structure may be similar to the "Müller cell barrier" that has been previously described in some animal models of retinal transplantation.12 This barrier, although not a continuous structure, has been postulated by some investigators to be an impediment to the formation of connections between host and transplant neurons. Methods aimed at reducing this "barrier" and improving grafthost integration are areas of active investigation in animal retinal transplantation. However, despite the membrane at the grafthost interface, neuronal processes were present between the transplant and the recipient retina in the patient described in this report. This observation is promising for the prospects of developing functional connections between the host retina and transplanted retinal tissue.
In summary, this report illustrates that long-term survival of fetal neural retinal tissue transplanted into the human subretinal space can be achieved without immunosuppression even in the absence of an intact bloodretina barrier. Although the transplant did not develop normal retinal architecture, the cells in the sheet transplant did develop and organize into layers. In addition, the transplanted tissue gave rise to both glial and neuronal cells. Well-differentiated photoreceptor outer segments did not develop in the transplanted tissue in this patient, but this may be because of the absence of subjacent RPE cells. The lack of RPE cells in this patient may be a result of previous subretinal surgery, AMD, the transplantation procedure itself, or a combination of all three processes. A fibrocellular membrane was evident between the transplant and the recipient retina and may be similar to the Müller cell "barrier" observed in animal models of retinal transplantation. Despite this membrane, apparent neuronal processes were present between the graft and the recipient retina. Future efforts should be directed toward enhancing grafthost integration and improving the techniques of transplantation (to allow more retinal cells to be transplanted while minimizing damage to existing host tissues). Nonetheless, the long-term survival of grafted tissue in the human subretinal space in the absence of immunosuppressive treatment is promising for future efforts in the field of neural retinal transplantation.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication March 25, 1999; revised November 10, 1999 and March 20, 2000; accepted March 31, 2000.
Commercial relationships policy: N.
Corresponding author: Eugene de Juan, Jr, Department of Ophthalmology, Wilmer Ophthalmological Institute, Johns Hopkins Hospital, 721 Maumanee, 600 N. Wolfe Street, Baltimore, MD 21287. edejuan{at}jhmi.edu
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. Canola, B. Angenieux, M. Tekaya, A. Quiambao, M. I. Naash, F. L. Munier, D. F. Schorderet, and Y. Arsenijevic Retinal Stem Cells Transplanted into Models of Late Stages of Retinitis Pigmentosa Preferentially Adopt a Glial or a Retinal Ganglion Cell Fate Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 446 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Khodair, M. A. Zarbin, and E. Townes-Anderson Synaptic Plasticity in Mammalian Photoreceptors Prepared as Sheets for Retinal Transplantation Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4976 - 4988. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Radner, S. R. Sadda, M. S. Humayun, S. Suzuki, M. Melia, J. Weiland, and E. de Juan Jr Light-Driven Retinal Ganglion Cell Responses in Blind rd Mice after Neural Retinal Transplantation Invest. Ophthalmol. Vis. Sci., April 1, 2001; 42(5): 1057 - 1065. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |